Trial Profile
Improvement of the Surveillance and Control of Liver Disease and Complication Due to Chronic Hepatitis C: Project A) Antiviral Drugs Use, Efficacy, Safety and Costs; Project B) Kinetics of Virological Response.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HEPCOVE
- 16 Sep 2010 New trial record